Harbin Gloria Pharmaceuticals Free Cash Flow Generation Index
Harbin Gloria Pharmaceuticals free cash flow generation index. Harbin Gloria Pharmaceuticals (002437) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of CN¥178.63 Million represents 1% of operating cash flow (CN¥182.89 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Harbin Gloria Pharmaceuticals (2007–2025)
Free cash flow generation index of Harbin Gloria Pharmaceuticals from 2007 to 2025. Historical FCF Generation Index trend for Harbin Gloria Pharmaceuticals across 19 annual periods. See Harbin Gloria Pharmaceuticals (002437) flexibility index to measure the company's free cash flow as a share of total liabilities.
Harbin Gloria Pharmaceuticals Free Cash Flow Generation Index by Year (2007–2025)
Harbin Gloria Pharmaceuticals free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for Harbin Gloria Pharmaceuticals. For the full cash flow conversion analysis, see Harbin Gloria Pharmaceuticals (002437) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥249.54 Million | CN¥273.36 Million | CN¥23.81 Million | ▲ +7.8% |
| 2024 | 0.85x | CN¥348.04 Million | CN¥410.94 Million | CN¥62.90 Million | ▼ -5.0% |
| 2023 | 0.89x | CN¥244.55 Million | CN¥274.18 Million | CN¥29.62 Million | ▲ +2.1% |
| 2022 | 0.87x | CN¥228.60 Million | CN¥261.62 Million | CN¥33.01 Million | ▼ 0.0% |
| 2021 | 0.87x | CN¥239.67 Million | CN¥274.18 Million | CN¥34.51 Million | ▲ +136.1% |
| 2020 | -2.42x | CN¥-30.90 Million | CN¥12.76 Million | CN¥43.66 Million | ▼ -362.9% |
| 2019 | 0.92x | CN¥561.94 Million | CN¥610.37 Million | CN¥48.43 Million | ▲ +1.1% |
| 2018 | 0.91x | CN¥1.06 Billion | CN¥1.16 Billion | CN¥104.34 Million | ▲ +29.8% |
| 2017 | 0.70x | CN¥457.16 Million | CN¥651.80 Million | CN¥194.63 Million | ▼ -14.7% |
| 2016 | 0.82x | CN¥855.14 Million | CN¥1.04 Billion | CN¥185.34 Million | ▲ +37.7% |
| 2015 | 0.60x | CN¥418.95 Million | CN¥702.05 Million | CN¥283.10 Million | ▼ -26.6% |
| 2014 | 0.81x | CN¥548.14 Million | CN¥674.04 Million | CN¥125.89 Million | ▲ +27.2% |
| 2013 | 0.64x | CN¥289.67 Million | CN¥453.02 Million | CN¥163.35 Million | ▲ +114.0% |
| 2012 | 0.30x | CN¥61.52 Million | CN¥205.89 Million | CN¥144.37 Million | ▲ +200.3% |
| 2011 | -0.30x | CN¥-38.30 Million | CN¥128.61 Million | CN¥166.90 Million | ▲ +73.9% |
| 2010 | -1.14x | CN¥-128.29 Million | CN¥112.59 Million | CN¥240.88 Million | ▼ -278.0% |
| 2009 | 0.64x | CN¥109.34 Million | CN¥170.82 Million | CN¥61.47 Million | ▲ +87.5% |
| 2008 | 0.34x | CN¥19.73 Million | CN¥57.81 Million | CN¥38.08 Million | ▼ -54.4% |
| 2007 | 0.75x | CN¥39.09 Million | CN¥52.26 Million | CN¥13.17 Million | — |